CStone Pharmaceuticals
Clinical trials sponsored by CStone Pharmaceuticals, explained in plain language.
A biopharmaceutical company focused on developing and commercializing cancer therapies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Triple-Action antibody takes on advanced cancers Results expected Jan 2027 (estimated)
-
Can a smart drug deliver a One-Two punch to advanced cancers?
Disease control PausedThis trial tests an experimental drug called CS5001, designed to seek out and destroy cancer cells that carry a specific marker (ROR1). It is being studied in people with advanced solid tumors or lymphomas that have progressed after standard treatments. The study will first find …
Phase 1 • Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New immunotherapy combo aims to fight advanced liver cancer
Disease control OngoingThis phase 3 study tests whether adding nofazinlimab (an immunotherapy) to lenvatinib (a standard targeted therapy) helps people with advanced liver cancer live longer. About 534 participants who have not had prior systemic treatment will receive either the combo or a placebo plu…
Phase 3 • Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New hope for lung cancer: targeted pill tested after other treatments fail
Disease control OngoingThis phase 2 trial is testing the drug lorlatinib in about 70 Chinese patients with advanced ROS1-positive non-small cell lung cancer that has worsened after prior treatments (crizotinib and chemotherapy). The goal is to see how many patients respond to the drug and how long the …
Phase 2 • Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC